John A. Scarlett

Insider Reports History

Location
C/O Geron Corporation, 230 Constitution Drive, Menlo Park, CA
Signature
/s/ Scott A. Samuels for John A. Scarlett
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Scarlett:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GERON CORP Chairman, President and CEO, Director Restricted Stock Units 410K $1.87M $4.56 Feb 18, 2025 Direct
GERON CORP Chairman, President and CEO, Director Common Stock 125K $221K $1.77 Feb 27, 2025 John A. Scarlett III 1999 Trust
GERON CORP Chairman, President and CEO, Director Common Stock 12.5K $22.1K $1.77 Feb 27, 2025 Direct
GERON CORP Chairman, President and CEO, Director Stock Option (right to buy) 2.46M Feb 18, 2025 Direct
CytomX Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 16, 2021 Direct
CHIASMA, INC Director Common Stock 0 Aug 5, 2021 Direct
CHIASMA, INC Director Stock Option (Right to Buy) 0 Aug 5, 2021 Direct

Insider Reports Filed by John A. Scarlett

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GERN GERON CORP Feb 27, 2025 1 $22.1K 4 Mar 3, 2025 Chairman, President and CEO, Director
GERN GERON CORP Feb 18, 2025 2 $0 4 Feb 20, 2025 Chairman, President and CEO, Director
GERN GERON CORP Jun 6, 2024 1 $0 4 Jun 7, 2024 Chairman, President and CEO, Director
GERN GERON CORP Jun 4, 2024 3 -$876K 4 Jun 5, 2024 Chairman, President and CEO, Director
GERN GERON CORP Feb 14, 2024 1 $0 4 Feb 16, 2024 CHAIRMAN, PRESIDENT AND CEO, Director
GERN GERON CORP Aug 15, 2023 1 $0 4 Sep 21, 2023 Chairman, President and CEO, Director
GERN GERON CORP Feb 22, 2023 1 $0 4 Feb 24, 2023 Chairman, President and CEO, Director
GERN GERON CORP Feb 8, 2023 9 -$2.06M 4 Feb 10, 2023 Chairman, President and CEO, Director
GERN GERON CORP Feb 16, 2022 1 $0 4 Feb 18, 2022 Chairman, President and CEO, Director
CHMA CHIASMA, INC Aug 5, 2021 6 $0 4 Aug 5, 2021 Director
CTMX CytomX Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director